Market Cap 120.41M
Revenue (ttm) 0.00
Net Income (ttm) -25.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 636,900
Avg Vol 905,056
Day's Range N/A - N/A
Shares Out 129.17M
Stochastic %K 16%
Beta 1.11
Analysts Sell
Price Target $5.69

Company Profile

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 588 0256
Fax: 206 902 9658
Address:
107 Spring Street, Seattle, United States
waterboy182
waterboy182 Oct. 25 at 11:48 PM
$ATOS I cant believe the Dumpster prick is still trolling here. Come on over to $SLS, the water is fine and results by EOY. Thank me later.
1 · Reply
Bunster
Bunster Oct. 25 at 9:41 PM
$ATOS for mr uber calvee the son of in&out and WB im bullish im bearish im bullish im bearish.ATOS PRICE TARGETS HAVE BEEN MEANINGLE3SS
0 · Reply
CJ27969
CJ27969 Oct. 25 at 8:13 PM
$ATOS $ATOS – Latest Analyst Price Targets (12M) • Ascendiant Capital – Edward Woo: $7.75 (Buy) – 9/22/2025 • H.C. Wainwright – Emily Bodnar: $7.00 (Buy) – 10/07/2025 (reiterated) • Craig-Hallum – Albert Lowe: $4.00 (Buy) – 6/05/2025 (initiation) • Maxim Group – Jason McCarthy: $4.00 (Buy) – 8/14/2025 (maintained) Consensus snapshot (varies by site): avg ≈ $6.25, range $4.00–$7.75 (3–5 analysts)
0 · Reply
The_Real_Heisenberg
The_Real_Heisenberg Oct. 25 at 7:52 PM
$ATOS if MM truly wanted to squeeze retail, they'd have dropped this further or continued to hold it down til the extension date. Thus increasing retails likelihood of selling (weak hands). But they made it compliant now. The company didn't need to do it now, and they've got better news ahead that they seem wildly confident about. Compliance has a significant effect on the ability of bigger fish to buy, and that is the only reason I can think of as to why someone would want this compliant right now instead of later. I.e, big fish are now interested. Large buys are happening. By January 2026, i forsee a real old school run.
2 · Reply
Warrens__Buffet_
Warrens__Buffet_ Oct. 25 at 5:59 PM
$ATOS fingers crossed for fast track submission news next week! Last week of breast cancer month 🙏🏼🙏🏼
1 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:35 AM
$ATOS We all welcome Atossa's faster development efforts aimed at addressing more immediate patient needs.👏
0 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:17 AM
$ATOS Thanks to ChatGPT's scientific analysis of the paradigm-concept.
0 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:13 AM
$ATOS Atossa's strategic paradigm shift (from a research-driven, long-horizon biotech paradigm to a market-oriented, short-term execution paradigm), takes a while to sink in and materialise. So let's be patient and give them all the support they need!
1 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 8:25 AM
$ATOS Next step, back to $ 1 coming week.
0 · Reply
JDAAT
JDAAT Oct. 25 at 2:44 AM
$ATOS at the blue jays game
1 · Reply
Latest News on ATOS
Atossa Therapeutics to Present at the Maxim Growth Summit 2025

Oct 15, 2025, 8:00 AM EDT - 10 days ago

Atossa Therapeutics to Present at the Maxim Growth Summit 2025


Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 10:05 AM EDT - 7 months ago

Atossa Therapeutics, Inc. (ATOS) Q4 2024 Earnings Call Transcript


waterboy182
waterboy182 Oct. 25 at 11:48 PM
$ATOS I cant believe the Dumpster prick is still trolling here. Come on over to $SLS, the water is fine and results by EOY. Thank me later.
1 · Reply
Bunster
Bunster Oct. 25 at 9:41 PM
$ATOS for mr uber calvee the son of in&out and WB im bullish im bearish im bullish im bearish.ATOS PRICE TARGETS HAVE BEEN MEANINGLE3SS
0 · Reply
CJ27969
CJ27969 Oct. 25 at 8:13 PM
$ATOS $ATOS – Latest Analyst Price Targets (12M) • Ascendiant Capital – Edward Woo: $7.75 (Buy) – 9/22/2025 • H.C. Wainwright – Emily Bodnar: $7.00 (Buy) – 10/07/2025 (reiterated) • Craig-Hallum – Albert Lowe: $4.00 (Buy) – 6/05/2025 (initiation) • Maxim Group – Jason McCarthy: $4.00 (Buy) – 8/14/2025 (maintained) Consensus snapshot (varies by site): avg ≈ $6.25, range $4.00–$7.75 (3–5 analysts)
0 · Reply
The_Real_Heisenberg
The_Real_Heisenberg Oct. 25 at 7:52 PM
$ATOS if MM truly wanted to squeeze retail, they'd have dropped this further or continued to hold it down til the extension date. Thus increasing retails likelihood of selling (weak hands). But they made it compliant now. The company didn't need to do it now, and they've got better news ahead that they seem wildly confident about. Compliance has a significant effect on the ability of bigger fish to buy, and that is the only reason I can think of as to why someone would want this compliant right now instead of later. I.e, big fish are now interested. Large buys are happening. By January 2026, i forsee a real old school run.
2 · Reply
Warrens__Buffet_
Warrens__Buffet_ Oct. 25 at 5:59 PM
$ATOS fingers crossed for fast track submission news next week! Last week of breast cancer month 🙏🏼🙏🏼
1 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:35 AM
$ATOS We all welcome Atossa's faster development efforts aimed at addressing more immediate patient needs.👏
0 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:17 AM
$ATOS Thanks to ChatGPT's scientific analysis of the paradigm-concept.
0 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 9:13 AM
$ATOS Atossa's strategic paradigm shift (from a research-driven, long-horizon biotech paradigm to a market-oriented, short-term execution paradigm), takes a while to sink in and materialise. So let's be patient and give them all the support they need!
1 · Reply
Henry20feb_
Henry20feb_ Oct. 25 at 8:25 AM
$ATOS Next step, back to $ 1 coming week.
0 · Reply
JDAAT
JDAAT Oct. 25 at 2:44 AM
$ATOS at the blue jays game
1 · Reply
Warrens__Buffet_
Warrens__Buffet_ Oct. 25 at 1:12 AM
$ATOS anyone know when can we expect an announcement or something? Getting pretty dull here.
0 · Reply
Bunster
Bunster Oct. 25 at 12:22 AM
$ATOS PRIMES WEEK IN REVIEW last week it was compliance compliance. THIS WEEK ITS 93C ON OCTOBER 24 2025 This week we have WB our new bagholding bull.I think formerly a bear last feb then switched to a bull in march saying 2 dollars next week. When that didnt work it was 2 dollars this summer.Then becoming a huge bear for a few months and recently is now a bull again.KNOW YOUR POSTER GIRLS. i think he may be starting to shake and needs daily assurances from rocketboy that we will go up and big.He didnt get the memo that rocketboys nickname is MISS. Raise your hands if u thought and posted last week that this week we will continue to go up. come on dont be shy.
0 · Reply
JDAAT
JDAAT Oct. 24 at 11:10 PM
$ATOS starts curling up
1 · Reply
The_Real_Heisenberg
The_Real_Heisenberg Oct. 24 at 8:55 PM
$ATOS funny, when i first went bearish, the ridicule i received from the bulls was insane. Now i go bullish and everyone gives me lip. Theres no winning on this board lol. Quays made everyone bitter as hell.
4 · Reply
Warrens__Buffet_
Warrens__Buffet_ Oct. 24 at 8:55 PM
$ATOS when do we moon?
1 · Reply
JDAAT
JDAAT Oct. 24 at 7:43 PM
0 · Reply
Bullrunners
Bullrunners Oct. 24 at 6:19 PM
$BURU $SLS $ATOS I love three of them!!!!
0 · Reply
OleGregg
OleGregg Oct. 24 at 5:49 PM
$SLS I hope this doesn't do what it did last after hours Friday...then dump Monday. Big week next week...lets run and hold! $ATOS please be next...please.
2 · Reply
Bullrunners
Bullrunners Oct. 24 at 5:17 PM
$SLS $ATOS $BURU I love them all!!!
0 · Reply
Warrens__Buffet_
Warrens__Buffet_ Oct. 24 at 4:29 PM
$ATOS pushing back to $1!
0 · Reply
DCalcote
DCalcote Oct. 24 at 4:24 PM
0 · Reply
Gwsgws
Gwsgws Oct. 24 at 3:59 PM
$ATOS is this the only stock that refuses to rise organically?
1 · Reply